Tekla Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $18.3M | Hold |
147,779
| – | – | 0.72% | 39 |
|
|
2023
Q1 | $21.6M | Sell |
147,779
-35,003
| -19% | -$5.18M | 0.82% | 35 |
|
|
2022
Q4 | $29.1M | Hold |
182,782
| – | – | 1.1% | 28 |
|
|
2022
Q3 | $24.4M | Buy |
182,782
+14,883
| +9% | +$2.26M | 1% | 31 |
|
|
2022
Q2 | $26.2M | Buy |
167,899
+27,426
| +20% | +$4.22M | 1.03% | 28 |
|
|
2022
Q1 | $21.9M | Buy |
140,473
+23,158
| +20% | +$3.36M | 0.77% | 35 |
|
|
2021
Q4 | $14.9M | Buy |
117,315
+3,256
| +3% | +$428K | 0.48% | 51 |
|
|
2021
Q3 | $14.9M | Buy |
114,059
+46,603
| +69% | +$7.04M | 0.48% | 54 |
|
|
2021
Q2 | $12M | Hold |
67,456
| – | – | 0.39% | 66 |
|
|
2021
Q1 | $11.1M | Hold |
67,456
| – | – | 0.38% | 70 |
|
|
2020
Q4 | $11.1M | Hold |
67,456
| – | – | 0.39% | 75 |
|
|
2020
Q3 | $9.62M | Hold |
67,456
| – | – | 0.36% | 64 |
|
|
2020
Q2 | $7.44M | Hold |
67,456
| – | – | 0.28% | 77 |
|
|
2020
Q1 | $6.73M | Sell |
67,456
-18,217
| -21% | -$2.36M | 0.3% | 66 |
|
|
2019
Q4 | $12.8M | Buy |
85,673
+10,737
| +14% | +$1.46M | 0.48% | 44 |
|
|
2019
Q3 | $9.6M | Buy |
74,936
+7,465
| +11% | +$1M | 0.42% | 57 |
|
|
2019
Q2 | $9.62M | Hold |
67,471
| – | – | 0.39% | 59 |
|
|
2019
Q1 | $9.64M | Sell |
67,471
-47,716
| -41% | -$6.22M | 0.39% | 53 |
|
|
2018
Q4 | $14.3M | Buy |
115,187
+4,735
| +4% | +$702K | 0.61% | 38 |
|
|
2018
Q3 | $18.6M | Hold |
110,452
| – | – | 0.67% | 38 |
|
|
2018
Q2 | $19M | Sell |
110,452
-12,030
| -10% | -$1.97M | 0.72% | 36 |
|
|
2018
Q1 | $18.5M | Buy |
122,482
+24,061
| +24% | +$3.53M | 0.72% | 34 |
|
|
2017
Q4 | $13.3M | Sell |
98,421
-175,495
| -64% | -$24.3M | 0.51% | 43 |
|
|
2017
Q3 | $40.1M | Hold |
273,916
| – | – | 1.43% | 19 |
|
|
2017
Q2 | $42.6M | Sell |
273,916
-57,495
| -17% | -$8.79M | 1.58% | 18 |
|
|
2017
Q1 | $48.1M | Hold |
331,411
| – | – | 1.86% | 17 |
|
|
2016
Q4 | $36.1M | Hold |
331,411
| – | – | 1.54% | 20 |
|
|
2016
Q3 | $40.3M | Buy |
331,411
+174,960
| +112% | +$23.6M | 1.55% | 19 |
|
|
2016
Q2 | $22.1M | Sell |
156,451
-22,640
| -13% | -$3.34M | 0.9% | 29 |
|
|
2016
Q1 | $23.4M | Buy |
+179,091
| New | +$22.3M | 0.99% | 25 |
|
|
2015
Q3 | – | Sell |
-120,357
| Closed | -$21.2M | – | 166 |
|
|
2015
Q2 | $21.2M | Sell |
120,357
-384
| -0.3% | -$69K | 0.77% | 30 |
|
|
2015
Q1 | $20.9M | Sell |
120,741
-80,600
| -40% | -$13.8M | 0.83% | 30 |
|
|
2014
Q4 | $33M | Buy |
201,341
+28,100
| +16% | +$4.66M | 1.54% | 17 |
|
|
2014
Q3 | $27.8M | Buy |
173,241
+77,284
| +81% | +$11.9M | 1.3% | 21 |
|
|
2014
Q2 | $14.1M | Buy |
+95,957
| New | +$13.3M | 1.29% | 20 |
|
Other funds holding JAZZ
SC
PCM
DTC
Tekla Capital Management's JAZZ Position: Q2 2023 in Review
Tekla Capital Management held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2023 at 147,779 shares worth $18.3M. The position accounts for 0.72% of the portfolio, ranked #39.
Tekla Capital Management first reported a position in JAZZ in Q2 2014 and has held it in 35 quarters since. The position peaked at $48.1M in Q1 2017. 471 funds tracked by Wall St. Rank hold JAZZ as of Q2 2023.
- Tekla Capital Management held 147,779 shares of Jazz Pharmaceuticals worth $18.3M as of Q2 2023.
- Tekla Capital Management left its Jazz Pharmaceuticals share count unchanged in Q2 2023.
- Jazz Pharmaceuticals made up 0.72% of Tekla Capital Management's portfolio in Q2 2023, its #39 holding.
- Tekla Capital Management first reported a position in Jazz Pharmaceuticals in Q2 2014 and has held it in 35 quarters since.
- Tekla Capital Management's Jazz Pharmaceuticals position peaked at $48.1M in Q1 2017.
- 471 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2023.
Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.